IPO Guru
Bajaj
Listed Mainboard

Sudeep Pharma IPO Subscription Status

Sudeep Pharma IPO was subscribed 93.72 times when bidding closed on 25 Nov 2025: QIB 213.08x, NII 116.72x, Retail 15.65x.

The Sudeep Pharma IPO has been subscribed 93.72x times overall. Retail investors have shown interest with bids for 15.65x the shares available. The Non-Institutional Investor (NII) category has been subscribed 116.72x. Within NII, Big HNI (B-HNI) subscribed 134.91x and Small HNI (S-HNI) subscribed 80.33x. Qualified Institutional Buyers (QIBs) have subscribed 213.08x. Data last updated on 03 Sep, 02:08 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 21 Nov, 2025 and closes on 25 Nov, 2025. The shares are expected to list on stock exchanges on 28 Nov, 2025.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 03 Sep 2026, 02:08 PM
Category Bid details Times
QIB - of 30,18,550 38,141.08 Cr 213.08x
NII - of 22,63,913 15,669.46 Cr 116.72x
bHNI — bid amount above ₹10 Lakh
- 12,074.65 Cr 134.91
sHNI — bid amount ₹2–10 Lakh
- 3,594.81 Cr 80.33
Retail - of 52,82,463 4,902.41 Cr 15.65x
TOTAL - 28,85,745 applications 58,712.94 Cr 93.72x
Advertisement

Sudeep Pharma IPO Basis of Allotment

Final Final figures published by the registrar, after technical rejections. Allotment price ₹593.

Applications
28,85,745
Allottees
2,17,991
Overall odds
1 out of 13
Amount collected
₹58,678 Cr
Category Apps Got Odds
TOTAL 65.56x subscribed 28,85,745 2,17,991 1 out of 13

Sudeep Pharma IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
1 out of 15
~6.4% chance per PAN — based on 15.65x subscription. Winners get exactly 1 lot (₹14,825) by SEBI lottery, however many lots you bid.
Small HNI (₹2–10 L)
1 out of 80
~1.2% chance — based on 80.33x subscription. Lottery allots the minimum S-HNI application of 14 lots (₹2.1 L) per winner; bidding bigger doesn't improve odds.
Big HNI (above ₹10 L)
1 out of 135
~0.7% chance — based on 134.91x subscription. Lottery allots the minimum NII application of 14 lots (₹2.1 L) per winner, the same as S-HNI; any shares left over are allotted proportionately.
QIB (institutions)
213.08x
Proportionate allotment — at 213.08x, institutions receive ~0.5% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x, so retail allotment is by lottery. Going by the multiple alone, that is about 1 out of 15 (~6.4%) per application — an estimate; the real odds are usually better because many applicants bid for more than one lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 213.08x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 3-day bidding window. On phones, tap a day for the category split.

Date Total
25 Nov 2025
Day 3
93.71x ▼
QIB213.08x BHNI- SHNI- Retail15.65x
24 Nov 2025
Day 2
5.13x ▼
QIB0.13x BHNI- SHNI- Retail5.02x
21 Nov 2025
Day 1
1.43x ▼
QIB0.09x BHNI- SHNI- Retail1.53x

Sudeep Pharma IPO dates

From the bidding window to listing. Today is 23 November.

Key dates Listed
  1. Open 21 Nov 2025
  2. Close 25 Nov 2025
  3. Allotment 26 Nov 2025
  4. Refund/credit 27 Nov 2025
  5. Listing 28 Nov 2025

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Sudeep Pharma IPO?

As of IPO close date (25 Nov, 2025), the Sudeep Pharma IPO is subscribed 93.72x times. Retail category is 15.65x, and NII is 116.72x subscribed.

When is the allotment date for Sudeep Pharma IPO?

The allotment for Sudeep Pharma IPO is expected to be finalized on 26 November, 2025.

What is the GMP of Sudeep Pharma?

The Grey Market Premium (GMP) for Sudeep Pharma is currently ₹93, indicating a potential listing gain of 16%.

When will Sudeep Pharma IPO list on the stock market?

Sudeep Pharma is scheduled to list on BSE and NSE on 28 November, 2025.

What are the chances of getting allotment in Sudeep Pharma IPO?

The retail category is oversubscribed at 15.65x, meaning allotment is by lottery. Going by the multiple alone, that is about 1 out of 15 (~6.4%) per application — an estimate; the real odds are usually better because many applicants bid for more than one lot. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 213.08x mean for Sudeep Pharma IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 213.08x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Sudeep Pharma IPO allotment status?

After the allotment date (26 Nov, 2025), you can check your Sudeep Pharma IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Sudeep Pharma IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
93.72x
QIB
213.08x
NII
116.72x
bHNI
134.91x
sHNI
80.33x
Retail
15.65x
Full IPO details
Advertisement